/PRNewswire/ Oncorena AB, which is developing a new and potentially groundbreaking treatment for patients with advanced kidney cancer, announces that the.
Year-end Report 2021/2022 - Preparations for the Upcoming US Launch newjerseytelegraph.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from newjerseytelegraph.com Daily Mail and Mail on Sunday newspapers.
DiviTum®TKa Predicts Clinical Outcome of Patients in BioItaLEE Study theusnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theusnews.com Daily Mail and Mail on Sunday newspapers.
13.06.2022 - UPPSALA, SE / ACCESSWIRE / June 13, 2022 / Biovica International (STO:BIOVIC-B) (STO:BIOVIC.B) (FRA:9II)Biovica today announced that the company s blood test DiviTum®TKa was highlighted in an oral presentation on June 6th at the ASCO Annual Meeting .